Rare Disease Peptides

Peptide Orphan Drugs and Rare Disease

Nearly half of FDA-approved orphan drugs are peptide-based. From setmelanotide for genetic obesity to elamipretide for Barth syndrome, rare diseases drive peptide innovation.